Caprotec Bioanalytics this week appointed Marc Voigt as managing director, chief financial officer, and chief operating officer.
Voigt comes to the company from Medical Enzymes where he was chief financial officer and chief business officer. Prior to that he was chief financial officer and chief business officer at Revotar Biopharmaceuticals.
Thermo Fisher Scientific said this week it has elected Lars Rebien Sorensen to its board of directors.
Sorensen is president and CEO of healthcare company Novo Nordisk. He is also a member of the supervisory board of Bertelsmann and a director of Dong Energy.
Robert McBurney this week was named CEO of the Accelerated Cure Project for Multiple Sclerosis.
Formerly the CEO of Cambridge Neuroscience, McBurney has held senior positions at firms including BG Medicine and TheraGenetics and is the co-founder of Differential Proteomics and Optimal Medicine.